Search for: "Alabama Controls, Inc." Results 201 - 220 of 484
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jan 2010, 3:23 am
(Spicy IP) Sanctity of Section 21 Patents Act (Spicy IP) ‘Abandoning’ legal fogginess: A proposal for patent clarity – section 21 Patents Act (Spicy IP) Court gives nod to patent for image on flowers: Speaking Roses International Inc v Controller-General Of Patents and Anr. [read post]
24 Jul 2019, 11:13 am by Helen Alvare
Planned Parenthood of Gulf Coast, Inc. and Andersen v. [read post]
4 Dec 2014, 11:05 am by John Elwood
Alabama, holding that life without parole for minors violates the Eighth Amendment. [read post]
28 Nov 2022, 12:56 pm by Cynthia Marcotte Stamer
Solutions Law Press, Inc. invites you receive future updates by registering on our Solutions Law Press, Inc. [read post]
13 Nov 2013, 12:16 pm by Eugene Volokh
Rock Star Videos, Inc., 547 F.3d 1095, 1099 (9th Cir. 2008); see also Univ. of Alabama Bd. of Trustees v. [read post]
5 Feb 2012, 7:55 am
Patent No. 6,101,531), an apparatus for controlling use of software added to a mobile device (U.S. [read post]
28 Apr 2013, 6:51 am by Bill Marler
These standards and requirements also clearly significantly control, affect and determine the growing, selection, packaging, shipping and storage elements for the cantaloupes. [read post]
4 Nov 2016, 4:39 am by Edith Roberts
For the Associated Press, Kim Chandler reports that the Supreme Court has stayed the execution of  Alabama death-row inmate Tommy Arthur, as the court considers whether to review Arthur’s challenge to Alabama’s death penalty procedure. [read post]
12 Jul 2012, 2:07 pm by P.J. Blount
Eddie Kato, CEO, Thales Alenia Space North America, Inc. [read post]
27 Apr 2018, 6:01 am
Posted by Vishal Gupta, Sandra Mortal, and Xiaohu Guo (University of Alabama), on Saturday, April 21, 2018 Tags: Compensation ratios, Diversity, Executive Compensation, Management Corporate Governance Deviance Posted by Ruth V. [read post]
27 Jan 2012, 7:13 am by Ed Wallis
As a result, the FDA ordered the drug’s manufacturer, Takeda Pharmaceuticals North America, Inc., to update Actos symptoms on the drug’s label earlier this fall. [read post]